Skip to main content
NCBI home page
Clinical Case Reports logoLink to Clinical Case Reports
. 2015 Sep 2;3(10):817–818. doi: 10.1002/ccr3.338

P16 and HPV discordance in metastatic carcinoma of cervical lymph nodes of unknown primary

Alyssa Ralph 1, Andrew Meyer 2, Ronald Sirota 3, Arthur Hooberman 2,✉
PMCID: PMC4614647  PMID: 26509014

Key Clinical Message

The prognostic utility of HPV in oropharyngeal squamous cell carcinoma (OPSCC) and non-OPSCC as has been well documented. Currently, a standardized IHC scoring system does not exist and is needed to define HPV positivity. We have recently seen a patient that provides a caution in using p16 status as a diagnostic aid.

Keywords: HPV, Oropharyngeal squamous cell carcinoma, P16, Unknown primary

Case

A 44-year-old nonsmoking male presented with a tender neck mass of several weeks duration. CT Neck revealed two enlarged right cervical lymph nodes. Flexible laryngoscopy revealed no obvious primary. A fine needle aspiration of the neck mass was felt to be most consistent with squamous cell carcinoma. PET/CT revealed three FDG-avid lymph nodes in the right neck and no evidence of distant metastases. He underwent a right selective neck dissection with bilateral tonsillectomies and directed biopsies of the nasopharynx, base of the tongue, and pyriform sinuses. Pathology revealed no evidence of a primary tumor, and eight of 10 right cervical lymph nodes positive for poorly differentiated carcinoma most consistent with squamous cell carcinoma. The tumor was strongly positive for p16 on IHC staining, supporting the diagnosis of a squamous cell carcinoma of the head and neck region with unknown primary site. He was treated with a conventional 7-week course of concomitant cisplatin and radiation therapy.

Post treatment PET/CT revealed recurrence in a single cervical lymph node and new hepatic metastases. Biopsy of the hepatic metastasis revealed mucoepidermoid carcinoma similar in morphology to the prior biopsy specimens. IHC was positive for p16. PCR testing was performed on both the original lymph node specimen and the liver metastasis; both were negative for HPV.

Discussion

P16, a cyclin-dependent kinase inhibitor, activates the cyclin D1 CKD4 and 6 complex, which prevents phosphorylation of the retinoblastoma protein (pRb) and leads to cell cycle arrest 1,2. Overexpression of p16 has been demonstrated in a wide range of human malignancies 3. HPV infection can lead to overexpression of p16 by virally-expressed oncoprotein E7 binding to and inactivating pRb, thus leading to overexpression of p16 1,2.

In this case, the expression of p16 in the setting of a metastatic carcinoma to cervical lymph nodes with squamous differentiation was taken as supporting evidence of an unknown primary squamous cell carcinoma of the head and neck region. The subsequent biopsy revealed mucoepidermoid salivary gland carcinoma, which has been shown to overexpress p16 in the absence of HPV infection 4–12. Thus, it is important to recognize that although IHC staining for p16 is a useful surrogate for HPV infection, discordance both due to testing inaccuracy as well as true p16 positivity without HPV infection exists and should be considered when evaluating a carcinoma originating in the head and neck region 1,4–15,17–20.

Conflict of Interest

None declared.

References

  1. Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, et al. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. J. Oral Pathol. Med. 2013;42:676–681. doi: 10.1111/jop.12086. [DOI] [PubMed] [Google Scholar]
  2. Rayess H, Wang MB. Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int. J. Cancer. 2012;130:1715–1725. doi: 10.1002/ijc.27316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doxtader EE. Katzenstein AL. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum. Pathol. 2012;43:327–332. doi: 10.1016/j.humpath.2011.05.010. [DOI] [PubMed] [Google Scholar]
  4. Isayeva T, Said-Al-Naief N, Ren Z, Li R, Gnepp D. Brandwein-Gensler M. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18. Head Neck Pathol. 2013;7:135–148. doi: 10.1007/s12105-012-0411-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jour G, West K, Ghali V, et al. Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 cases. Head Neck Pathol. 2013;7:224–231. doi: 10.1007/s12105-012-0417-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Skálová A, Kašpírková J, Andrle P, Hosticka L. Vanecek T. Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Cesk. Patol. 2013;49:72–75. [PubMed] [Google Scholar]
  7. Tarakji B, Baroudi K, Darwish S, Sakka S. Hanouneh S. Immunohistochemical expression of p16 in pleomorphic salivary adenoma. Turk Patoloji Derg. 2013;29:36–40. doi: 10.5146/tjpath.2013.01145. [DOI] [PubMed] [Google Scholar]
  8. Brunner M, Koperek O, Wrba F, Erovic BM, Heiduschka G, Schoppper C, et al. HPV infection and p16 expression in carcinomas of the minor salivary glands. Eur. Arch. Otorhinolaryngol. 2012;269:2265–2269. doi: 10.1007/s00405-011-1894-2. [DOI] [PubMed] [Google Scholar]
  9. Vékony H, Röser K, Löning T, Raaphorst FM, Leemans CR, Van der Waal I, et al. Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands. Histopathology. 2012;53:658–666. doi: 10.1111/j.1365-2559.2008.03184.x. [DOI] [PubMed] [Google Scholar]
  10. Zhu S, Wang X, Shao L, Chen W, Chen X. Wu H. Quantitative study on expression of p16 multiple tumor suppressor gene in salivary gland neoplasm. J. Tongji Med. Univ. 1999;19:155–157. doi: 10.1007/BF02886899. [DOI] [PubMed] [Google Scholar]
  11. Gong L, Chen ZL, Hu J. Huo HY. Expression of p16 and nm23 genes in salivary gland tumors. Hua Xi Kou Qiang Yi Xue Za Zhi. 2004;22:155–157. , and Chinese. [PubMed] [Google Scholar]
  12. Cerilli LA, Swartzbaugh JR, Saadut R, Marshall CE, Rumpel CA, Moskaluk CA, et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum. Pathol. 1999;30:1242–1246. doi: 10.1016/s0046-8177(99)90044-8. [DOI] [PubMed] [Google Scholar]
  13. Masand RP, El-Mofty SK, Ma XJ, Luo Y, Flanagan JJ. Lewis Jr JS. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5:108–116. doi: 10.1007/s12105-011-0245-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. König F, Krekeler G, Hönig JF, Cordon-Cardo C, Fischer G. Korabiowska M. Relation between human papillomavirus positivity and p16 expression in head and neck carcinomas–a tissue microarray study. Anticancer Res. 2007;27:283–288. [PubMed] [Google Scholar]
  15. Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, et al. p16 Protein expression and human papillomavirus status as prognostic biomarkers of non-oropharyngeal head and neck squamous cell carcinoma. J. Clin. Oncol. 2014;32:3930–3938. doi: 10.1200/JCO.2013.54.5228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Singhi AD. Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166–2173. doi: 10.1002/cncr.25033. [DOI] [PubMed] [Google Scholar]
  17. Smeets SJ, Hesselink AT, Speel E-JM, Haeseviets A, Snijders PJF, Pawlita M, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer. 2007;121:2465–2472. doi: 10.1002/ijc.22980. [DOI] [PubMed] [Google Scholar]
  18. Begum S, Gillison ML, Nicol TL. Westra WH. Detection of human papilloma virus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin. Cancer Res. 2003;9:6469–6475. [PubMed] [Google Scholar]
  19. De Braud F. al Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin. Oncol. 1993;20:273–278. [PubMed] [Google Scholar]
  20. Lewis JS, Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q, et al. P16 Positive oropharyngeal squamous cell carcinoma: an entity with a favourable prognosis regardless of tumor HPV status. Am. J. Surg. Pathol. 2010;34:1088–1096. doi: 10.1097/PAS.0b013e3181e84652. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES